3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 2
1
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Head and Neck Neoplasms
4
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Ovarian Neoplasms
2
Medulloblastoma
2
Fallopian Tube Neoplasms
2
Tonsillar Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pinealoma
1
Pharyngeal Neoplasms
1
Pelvic Neoplasms
1
Pancreatic Adenocarcinoma
1
Ototoxicity
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Mesothelioma, Malignant
1
Lymphoma, B-Cell
1
Liposarcoma
1
Hepatoblastoma
1
Esophageal Squamous Cell Carcinoma
1
EGFR Positive Non-small Cell Lung Cancer
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Interventions
sodium thiosulfate
1
X-Rays
1
Specimen Handling
1
Platinum
1
Magnetic Resonance Spectroscopy
1
Hyperthermic Intraperitoneal Chemotherapy
1
Doxorubicin
1
Cytoreduction Surgical Procedures
1
Cisplatin
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Rhabdomyosarcoma
×
Cisplatin
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled